We Dissent: Lessons From the 2025 Community-Acquired Pneumonia Guidelines
Clinical Infectious Diseases · 30.04.2026 · 82 (4) · 625-629
DOI: 10.1093/cid/ciaf626 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 04.12.2025. Verfasst von Leila S Hojat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Disease, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Community-Acquired Infections, Anti-Bacterial Agents, Practice Guidelines as Topic, Pneumonia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Clinical practice guidelines profoundly influence patient care, making transparency, rigor, and fairness in their development essential. The 2025 community-acquired pneumonia (CAP) guideline update, developed by the American Thoracic Society (ATS) and initially co-sponsored by the Infectious Diseases Society of America (IDSA), included a recommendation to prescribe antibacterials for CAP upon detection of a respiratory viral pathogen. Here, we acknowledge the guidelines' strengths with respect to supporting shorter treatment duration but highlight the lack of supporting data for antibacterial therapy in CAP with a respiratory virus. We additionally reflect on shortcomings in the guideline development process itself, which may have led to this recommendation, including meeting logistics, communication, and methodology, using these observations to offer suggestions for future infectious diseases guidelines panels. Despite the unfortunate outcome, we commend IDSA for their difficult but principled decision to withdraw support, preserving stewardship priorities and the commitment to first do no harm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Infectious Disease, Emory University, Atlanta, Georgia, USA.
- Department of Internal Medicine, Division of Infectious Disease, Rochester Regional Health System, Rochester, New York, USA.
- Infectious Disease, Corewell Health West Medical Group, Grand Rapids, Michigan, USA.
- Department of Internal Medicine, Division of General Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Leila S Hojat, Valerie M Vaughn
Zitieren
APA
Hojat, L. S., Laguio-Vila, M. R., Sullivan, L. R., & Vaughn, V. M. (2026). We Dissent: Lessons From the 2025 Community-Acquired Pneumonia Guidelines. Clinical Infectious Diseases, 82(4), 625-629. https://doi.org/10.1093/cid/ciaf626
Vancouver
Hojat LS, Laguio-Vila MR, Sullivan LR, Vaughn VM. We Dissent: Lessons From the 2025 Community-Acquired Pneumonia Guidelines. Clinical Infectious Diseases. 2026;82(4):625-629. doi:10.1093/cid/ciaf626
BibTeX
@article{Hojat2026,
author = {Hojat, Leila S and Laguio-Vila, Maryrose R and Sullivan, Liam R and Vaughn, Valerie M},
title = {We Dissent: Lessons From the 2025 Community-Acquired Pneumonia Guidelines},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {4},
pages = {625--629},
doi = {10.1093/cid/ciaf626}
}
EUVIMED